Navigation Links
Prototype, 7-foot-tall sanitizer automates disinfection of hard-to-clean hospital equipment
Date:7/31/2009

Johns Hopkins experts in applied physics, computer engineering, infectious diseases, emergency medicine, microbiology, pathology and surgery have unveiled a 7-foot-tall, $10,000 shower-cubicle-shaped device that automatically sanitizes in 30 minutes all sorts of hard-to-clean equipment in the highly trafficked hospital emergency department. The novel device can sanitize and disinfect equipment of all shapes and sizes, from intravenous line poles and blood pressure cuffs, to pulse oximeter wires and electrocardiogram (EKG) wires, to computer keyboards and cellphones.

The invention, nicknamed "SUDS" for self-cleaning unit for the decontamination of small instruments, has already been shown to initially disinfect noncritical equipment better than manual cleaning, they report in the Annals of Surgical Innovation and Research online July 30.

Study senior author and surgeon Bolanle Asiyanbola, M.D., says the four-year SUDS project was initially sparked by the rapid rise in use of expensive disposable items, a trend linked to efforts to prevent bacterial infections among and between patients in hospitals.

Drawing on her experience in the operating room, where many batches of surgical clamps, retractors and scalpels have been sterilized, decontaminated and safely re-used for decades, Asiyanbola put together a team to end what she calls the "wasteful and unnecessary" practice of wiping down a lot of heavily used items with disinfectants and applying a lot of elbow grease. "If we can safely re-use equipment in the operating room, then we can do it elsewhere in the hospital for non-critical equipment," she says.

In the study, the Johns Hopkins team showed that SUDS was able to disinfect some 90 pieces of used emergency-room equipment, placing as many as 15 items in the device and "fogging" the equipment with an aerosolized, commercially available disinfectant chemical, or biocide, called Sporicidin. None of the electronic
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Swine Flu Pandemic Causes Public Concerns About Hand Sanitizers
2. Q-Based Healthcare Warns: Hand Sanitizers Increase Risk of Swine Flu Exposure
3. Oust(R) Surface Disinfectant & Air Sanitizer Effective Against H1N1
4. Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic
5. Facts About Hand Sanitizers as Public Concerns Over the Swine Flu Increase
6. Skinvisibles DermSafe(R) Hand Sanitizer Kills Swine Flu Virus
7. SkinWear(TM) Hand Cleaner & Sanitizer Kills Germs That May Cause Swine Flu, Protects Against Germs for Up to Eight Hours
8. ReStockIt.com Greatly Cutting Prices on Hand Sanitizers, Masks to Help Combat Swine Flu Epidemic
9. It Pays to Use Prevention This Cold & Flu Season With Help From NOZIN(R) Nasal Sanitizer(R)
10. Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work
11. Fastrack Automates Workflow For Homecare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prototype, 7-foot-tall sanitizer automates disinfection of hard-to-clean hospital equipment
Prototype, 7-foot-tall sanitizer automates disinfection of hard-to-clean hospital equipment
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...arguments by critics, a University of Utah-led stu...e in Oregon and the Netherlands did not result in ...rly, poor, women, minorities, uninsured, minors, c...ide at elevated rates. , Fears about the impact ...
...f., Sept. 26 AARP asks,Governor Schwarzenegger to... children currently enrolled in the State Children...e of Representatives passed a bill,which would exp...xpand the program too much. In a letter to the ad...
...exclusive North American rights to bepotastine for...RVINE, Calif., Sept. 26 ISTA,Pharmaceuticals, Inc...d,exclusive North American rights to nasal dosage ...ve North American rights,to ophthalmic allergy app...
..., Sept. 26 While the fall season has,officially b... parasites,lingers with the season,s warm weather....animal health news, offers pet owners these facts ...ronments and feed on the blood of their hosts....
...on of no causal link disputes its own data while s... spotlight conflicts of interest, NIXA, Mo., Sept...hat a CDC study of only 1047 participants, low,com... public. They question how such a poor quality stu...
...t antibody explains why even ,matched, organs get ...y News) -- Researchers say a newly discovered immu...ections and may explain why otherwise well-matched...author and assistant professor of internal medicin...
Other Medicine News:Health News:Doctor-aided suicide: No slippery slope 2Health News:Doctor-aided suicide: No slippery slope 3Health News:Doctor-aided suicide: No slippery slope 4Health News:AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 3Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 4Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 5Health News:Summer Temperatures Linger, Extend Threat of Parasites 2Health News:CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ 2Health News:Scientists Spot Key to Kidney Transplant Success 2Health News:Scientists Spot Key to Kidney Transplant Success 3Health News:Scientists Spot Key to Kidney Transplant Success 4
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4National Greatness Contest Winners Announced 58136 1National Greatness Contest Winners Announced 58136 2National Greatness Contest Winners Announced 58136 3MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 1MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 1Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 3Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 4Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 5
...-Dose Protection Observed Prior to or Up to 24 Hou...y 24, 2007 /PRNewswire/ -- Targanta,Therapeutics C...nt,study demonstrating oritavancin as a potential ...s, the bacterium which causes anthrax,an acute in...etic,lipoglycopeptide antibiotic for the treatment...
...EY HEIGHTS, N.J.--(BUSINESS WIRE)--May 24, 2007 - ...AQ: CYCCP) announced today,that it will report res...abine (CYC682), a novel orally-available nucleosid...yelodysplastic syndromes,(MDS), at the American So... at McCormick Place in Chicago. Details of the pre...
Other Medicine Technology:Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 2Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 3Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 4Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting 2Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting 3
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: